Montgomery County biotech to spin out subsidiary in SPAC merger The Business Journals
The SPAC Sponsor Behind Lucid and Oklo Is Taking Agility Robotics Public on Nov. 5. Here’s What Those 2 Stocks Did in Their First 90 Days. – Yahoo Finance
The SPAC Sponsor Behind Lucid and Oklo Is Taking Agility Robotics Public on Nov. 5. Here’s What Those 2 Stocks Did in Their First 90…
Space SPAC FutureCorp posts $1.9M net income, $233M in trust in first report – Dealroom
Space SPAC FutureCorp posts $1.9M net income, $233M in trust in first report Dealroom
Tokenisation fintech tZERO to go public via SPAC deal – FinTech Futures
Tokenisation fintech tZERO to go public via SPAC deal FinTech Futures
Dronamics to List on Nasdaq via SPAC Deal at ~€447M Value – The Recursive
Dronamics to List on Nasdaq via SPAC Deal at ~€447M Value The Recursive
Agility Robotics shares set to start trading Thursday – The Business Journals
Agility Robotics shares set to start trading Thursday The Business Journals
Churchill Capital XI shareholders approve $2.5B Agility Robotics humanoid SPAC – The Robot Report
Churchill Capital XI shareholders approve $2.5B Agility Robotics humanoid SPAC The Robot Report
PlusAI files registration document for SPAC merger ahead of 2027 driverless launch – Trucking Dive
PlusAI files registration document for SPAC merger ahead of 2027 driverless launch Trucking Dive
Tokenization firm tZERO plans to go public in $350 million SPAC deal – CoinDesk
Tokenization firm tZERO plans to go public in $350 million SPAC deal CoinDesk
Defense, space firms turn to SPACs as investor appetite soars – Reuters
Defense, space firms turn to SPACs as investor appetite soars Reuters
Humanoid developer Agility now expects to raise $465M in SPAC deal – The Robot Report
Humanoid developer Agility now expects to raise $465M in SPAC deal The Robot Report
Aspen, Bambusa close IPOs as Corxel takes SPAC route – pharmaphorum
Aspen, Bambusa close IPOs as Corxel takes SPAC route pharmaphorum
IPO & SPAC Market Update: Q3 2026 – FTI Consulting
IPO & SPAC Market Update: Q3 2026 FTI Consulting
Corxel claims oral obesity drug is in the ‘right lane’ as biotech plans SPAC route to Nasdaq – Fierce Biotech
Corxel claims oral obesity drug is in the ‘right lane’ as biotech plans SPAC route to Nasdaq Fierce Biotech
Corxel, an obesity drugmaker, to go public via SPAC deal – BioPharma Dive
Corxel, an obesity drugmaker, to go public via SPAC deal BioPharma Dive
Obesity drug developer Corxel to go public in US via SPAC deal – Reuters
Obesity drug developer Corxel to go public in US via SPAC deal Reuters
Corxel to take oral GLP-1 public in the US via SPAC – Endpoints News
Corxel to take oral GLP-1 public in the US via SPAC Endpoints News
Broker admits role in SPAC insider trading – Investment Executive
Broker admits role in SPAC insider trading Investment Executive
Obesity drug developer Corxel to go public in US via SPAC deal – KELO-AM
Obesity drug developer Corxel to go public in US via SPAC deal KELO-AM
Nice Work If You Can Getty – Puck
Nice Work If You Can Getty Puck